Items where Author is "Nateghi, A."

Article

(2024) Effectiveness and medication adherence in patients with ST- elevated myocardial infarction: Persian polypill study. Arya Atherosclerosis. pp. 43-53. ISSN 1735-3955 (Print) 2251-6638 (Electronic) 1735-3955 (Linking)

(2024) A Review of Fixed-Dose Combination Therapy for Secondary Prevention of Adverse Cardiovascular Events and the Preliminary Results of the Persianpolypill Randomized Clinical Trial. Journal of Isfahan Medical School. pp. 499-512. ISSN 10277595 (ISSN)

(2022) Fixed Dose Combination Therapy for Secondary Prevention of Major Cardiovascular Events: Review of Literature and Design for Persian Polypill, A Randomized Clinical Trial. CURRENT PROBLEMS IN CARDIOLOGY. ISSN 0146-2806 1535-6280 J9 - CURR PROB CARDIOLOGY

(2021) Fixed Dose Combination Therapy for Secondary Prevention of Major Cardiovascular Events: Review of Literature and Design for Persian Polypill, A Randomized Clinical Trial. Curr Probl Cardiol. p. 100872. ISSN 0146-2806

(2019) Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial. Lancet. pp. 672-683. ISSN 0140-6736

(2018) SD1000: 96.4 SVR12 in 1237 patients with hepatitis C genotypes 1, 2, 3, 4 using co-formulated sofosbuvir/daclatasvir tablets manufactured in Iran - a multicenter phase 3 clinical trial including HIV co-infected, transplant, and hemodialysis patients. Journal of Viral Hepatitis. pp. 198-199. ISSN 1352-0504

(2015) Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial. European Journal of Preventive Cardiology. pp. 1609-1617. ISSN 2047-4873